Упрощенная HTML-версия
РОЗДІЛ 8. ВЕДЕННЯ ВАГІТНИХ З ПАТОЛОГІЧНИМИ СТАНАМИ
203
66. Mercer BM, Miodovnik M, Thurnau GR, et al. Antibiotic therapy for reduction of infant
morbidity after preterm premature rupture of the membranes. A randomized controlled trial.
National Institute of Child Health and Human Development Maternal-Fetal Medicine Units
Network. JAMA 1997; 278: 989–95.
67. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour
rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group.
Lancet 2001; 357: 979–88.
68. Deulofeut R, Sola A, Lee B, et al. The impact of vaginal delivery in premature infants weighing
less than 1251 grams. Obstet Gynecol 2005; 105: 525–31.
69. Riskin A, Riskin-Mashiah S, Lusky A, et al. The relationship between delivery mode and
mortality in very low birthweight singleton vertex-presenting infants. BJOG 2004; 111: 1365–
71.
70. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at
risk of preterm birth for neuroprotection of the fetus. The Cochrane Database of Systematic
Reviews 2007, Issue 3. Art. No.:CD004661. DOI: 10.1002/14651858.CD004661.pub3.
71. Magnesium Sulphate for Fetal Neuroprotection. Clinical Practice Guidelines No. 258. Society
of Obstetricians and Gynaecologists of Canada, May 2011.
72. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in
threatened preterm labour. The Cochrane Database of Systematic Reviews 2002, Issue 4.
Art. No.:CD001060. DOI: 10.1002/14651858.CD001060.
73. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Review. The Cochrane
Library, 2004, Issue 4.
74. Garite TJ, et al. Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter
randomized placebo-controlled trial. Obstetrics Collaborative Research Network. Am J Obstet
Gynecol 2009; 200:248.e1–248.e9.
75. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal
colonization. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007467.
DOI: 10.1002/14651858.CD007467.pub2.
76. Naik Gaunekar N, Crowther CA. Maintenance therapy with calcium channel blockers for
preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic
Reviews 2004, Issue 3. Art. No.: CD004071. DOI: 10.1002/14651858.CD004071.pub2.
77. Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth
after threatened preterm labour. Cochrane Database of Systematic Reviews 2010, Issue 7.
Art. No.: CD000940. DOI: 10.1002/14651858.CD000940.pub2.
78. Papatsonis D, Flenady V, Liley H. Maintenance therapy with oxytocin antagonists for
inhibiting preterm birth after threatened preterm labour. Cochrane Database of Systematic
Reviews 2009, Issue 1. Art. No.: CD005938. DOI:10.1002/14651858.CD005938.pub2.
79. Dodd JM, Crowther CA, Dare MR, Middleton P. Oral betamimetics for maintenance therapy
after threatened pretermlabour. Cochrane Database of Systematic Reviews 2006, Issue 1.
Art. No.: CD003927. DOI: 10.1002/14651858.CD003927.pub2.
80. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane
Database of Systematic Reviews 2010, Issue 8. Art. No.: CD001058. DOI:
10.1002/14651858.CD001058.pub2.
81. Lasswell SM, Barfield WD, Rochat RW, Blackmon L. Perinatal regionalization for very low-
birth-weight and very preterm infants: a meta-analysis. JAMA. 2010; 304(9):992-1000